CMS delays rule for breakthrough medical technologies for 2nd time

CMS further delayed a final rule that aims to speed up FDA approval for Medicare coverage of breakthrough medical devices and technologies.

Advertisement

The Medicare Coverage of Innovative Technology rule will be delayed until Dec. 15. CMS made the announcement in an interim final rule scheduled to be filed in the federal register May 18. 

The second delay will provide “CMS an opportunity to address all of the issues raised by stakeholders, especially Medicare patient protections, evidence criteria and lack of coordination between coverage, coding and payment as noted previously,” CMS wrote in the interim final rule.

The rule was initially delayed by the Biden administration in March. The Biden administration postponed the effective date to May 15 as part of its strategy to review policies released toward the end of former President Donald Trump’s term.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Reconsider What’s Possible: Enterprise RCM and the Pro-Fee Practice

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Garett Kreitz, Med-MetrixJohn Stefanowicz, Med-Metrix

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.